Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carnival Corp (CCL) vs GeneDx Holdings Corp (WGS) Price & Performance

Carnival CorpTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Carnival Corp vs GeneDx Holdings Corp — how do they compare? Carnival Corp trades at $27.52 (market cap $37.98B), while GeneDx Holdings Corp trades at $82.62 (market cap $2.44B). The key difference: Carnival Corp is far larger — about 15.6× GeneDx Holdings Corp's market cap, and Carnival Corp pays a 1.62% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

CCLWGS
Market Cap
$37.98B$2.44B
Sector
Consumer CyclicalTechnology
52-Week High
$33.99$167.51
52-Week Low
$23.89$34.51
Enterprise Value
$61.91B$2.48B
Dividend Yield
1.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Carnival Corp

Carnival Corporation (CCL) trades at $27.75, down 4.28% today, amid a bearish technical signal. The company shows strong fundamental recovery with revenue growing from $12.2B in 2022 to $26.6B in 2025, net income turning positive to $2.76B, and positive cash flow of $727M in 2025. Recent earnings beats and a 59.57% analyst buy rating support optimism, though technical indicators show near-term pressure with support at $27.

Outlook remains positive driven by record travel demand, fleet expansion, and debt reduction, with a consensus price target of $35.18 offering 27% upside. Key risks include fuel price volatility, economic sensitivity, and execution of growth plans amid competitive pressures.

GeneDx Holdings Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Carnival Corp

Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.

Read more on CCL

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS